1. PR interval prolongation, still a marker of worse outcome in patients treated cardiac resynchronization therapy patients

   Van Stipdonk, A. M. W. A. M. W., Dural, M., Salden, F., Ter Horst, I. A. H., Crijns, H. J. G. M., Prinzen, F. W., Meine, M., Maass, A. H. & Vernooy, K., May-2019, In : European Journal of Heart Failure. 21, p. 373 1 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

2. Baseline characteristics determine long-term outcome to CRT, intermediate endpoints identify those at risk of adverse events.

   Van Stipdonk, A. M. W. A. M. W., Ghossein, M., Kloosterman, M., Ter Horst, I. A. H., Prinzen, F. W., Meine, M., Vernooy, K. & Maass, A. H., May-2019, In : European Journal of Heart Failure. 21, p. 374 1 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

3. Response to cardiac resynchronization therapy is present across all stages of chronic kidney disease

   Ter Maaten, J. M. J., Martens, P., Maass, A. H., Damman, K., Dupont, M. & Mullens, W., May-2019, In : European Journal of Heart Failure. 21, p. 347 1 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

4. ECG predictors of outcome in non-left bundle branch block cardiac resynchronization therapy patients

   Van Stipdonk, A. M. W. A. M. W., Dural, M., Salden, F. C. W. M., Ter Horst, I. A. H., Crijns, H. J. G., Prinzen, F. W., Meine, M., Maass, A. H. & Vernooy, K., May-2019, In : European Journal of Heart Failure. 21, p. 508-509 2 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

5. Dyssynchronopathy Can be a Manifestation of Heritable Cardiomyopathy

   Te Rijdt, W. P., Hoedemaekers, Y. M., Jongbloed, J. D. H., Damman, K., van der Zwaag, P. A., de Boer, R. A., Maass, A. H. & van den Berg, M. P., May-2019, In : Circulation. Genomic and precision medicine. 12, 5, 2 p., 002528.

   Research output: Contribution to journal › Letter › Academic › peer-review

View all (124) »